Top 5 advances in medicine this week (🧵)
1. The GLP1 receptor agonist, Semaglutide, reduces cravings for alcohol and cigarettes
This is a randomised phase 2 study with 48 patients
The dose used was much lower than the dose for obesity, but still causes weight loss, so the trial was restricted to patients with BMI > 23
This could add new indications to a growing list of uses for GLP1s
https://t.co/3Meel3raBk
Check out this cool new paper fresh out of the Evans lab! RIG-I has novel pattern recognition abilities to bind to DNA-like molecules!
https://t.co/1HEnQ4zmsG
There are people who make invaluable contributions to science, whose names are never included in author lists.
They are the unsung heroes of science; its communicators, administrators, illustrators and technicians https://t.co/dGV4yWj3qT
Lubert Stryer (1938—2024) "pioneered fluorescence methods for measuring distances within macromolecules, elucidated the visual signal transduction cascade, and helped develop DNA microarrays."
Read more about his life in a new #ScienceRetrospective: https://t.co/yGatPidkdg
“Do not undertake a scientific career in quest of fame or money. There are easier and better ways to reach them. Undertake it only if nothing else will satisfy you; for nothing else is probably what you will receive.”
— Cecilia Payne-Gaposchkin (1900-1979)
Chandrayaan-3 Mission:
'India🇮🇳,
I reached my destination
and you too!'
: Chandrayaan-3
Chandrayaan-3 has successfully
soft-landed on the moon 🌖!.
Congratulations, India🇮🇳!
#Chandrayaan_3#Ch3